Education
About Us
Working with TipRanks
Follow Us
Jaguar Animal Health Inc. (JAGX)
:JAGX
JAGX Stock Chart & Stats
$1.28
-$0.07(-5.93%)
At close: 4:00 PM EST
$1.28
-$0.07(-5.93%)
Day’s Range― - ―
52-Week Range$1.00 - $33.25
Previous CloseN/A
Volume188.05K
Average Volume (3M)187.27K
Market Cap
$4.11M
Enterprise Value$33.12M
Total Cash (Recent Filing)$3.53M
Total Debt (Recent Filing)$31.90M
Price to Earnings (P/E)―
Beta1.87
Next Earnings
Apr 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.28
Shares Outstanding3,735,837
10 Day Avg. Volume341,331
30 Day Avg. Volume187,272
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.76
Price to Sales (P/S)0.64
P/FCF Ratio-0.25
Enterprise Value/Market Cap8.06
Enterprise Value/Revenue2.81
Enterprise Value/Gross Profit3.64
Enterprise Value/Ebitda-0.80
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Jaguar Animal Health News
JAGX FAQ
What was Jaguar Animal Health Inc.’s price range in the past 12 months?
Jaguar Animal Health Inc. lowest stock price was $1.00 and its highest was $33.25 in the past 12 months.
What is Jaguar Animal Health Inc.’s market cap?
Jaguar Animal Health Inc.’s market cap is $4.11M.
When is Jaguar Animal Health Inc.’s upcoming earnings report date?
Jaguar Animal Health Inc.’s upcoming earnings report date is Apr 06, 2026 which is in 115 days.
How were Jaguar Animal Health Inc.’s earnings last quarter?
Jaguar Animal Health Inc. released its earnings results on Nov 17, 2025. The company reported -$6.28 earnings per share for the quarter, missing the consensus estimate of N/A by -$6.28.
Is Jaguar Animal Health Inc. overvalued?
According to Wall Street analysts Jaguar Animal Health Inc.’s price is currently Overvalued.
Does Jaguar Animal Health Inc. pay dividends?
Jaguar Animal Health Inc. does not currently pay dividends.
What is Jaguar Animal Health Inc.’s EPS estimate?
Jaguar Animal Health Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jaguar Animal Health Inc. have?
Jaguar Animal Health Inc. has 3,735,837 shares outstanding.
What happened to Jaguar Animal Health Inc.’s price movement after its last earnings report?
Jaguar Animal Health Inc. reported an EPS of -$6.28 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.124%.
Which hedge fund is a major shareholder of Jaguar Animal Health Inc.?
Currently, no hedge funds are holding shares in JAGX
Company Description
Jaguar Animal Health Inc.
Jaguar Animal Health, Inc. (JAGX) is a biotechnology company focused on developing and commercializing innovative animal health products for the veterinary market. The company specializes in the development of therapeutics for companion animals and livestock, particularly targeting gastrointestinal health and other unmet medical needs. Jaguar's core products include a range of prescription medications and nutraceuticals aimed at enhancing the health and well-being of animals, leveraging its proprietary technology platforms to create effective solutions.
JAGX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a positive outlook with significant revenue growth and successful clinical trial results for crofelemer, along with strategic regulatory advancements and expansion plans in the animal health market. However, these positive developments were offset by increased operational losses and net loss attributable to shareholders.View all JAGX earnings summariesTechnical Analysis
Galmed Pharmaceuticals
―
Soligenix
―
Revelation Biosciences
―
Dermata Therapeutics
―
60 Degrees Pharmaceuticals, Inc.
―
Ownership Overview
6.60% Insiders
0.85% Mutual Funds
2.45% Other Institutional Investors
90.05% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---